Population-Level Sexual Mixing According to HIV Status and Preexposure Prophylaxis Use Among Men Who Have Sex With Men in Montreal, Canada: Implications for HIV Prevention.
Adolescent
Adult
Anti-HIV Agents
/ therapeutic use
Cross-Sectional Studies
HIV Infections
/ prevention & control
HIV Serosorting
/ statistics & numerical data
Humans
Male
Pre-Exposure Prophylaxis
/ statistics & numerical data
Quebec
Sexual Behavior
/ statistics & numerical data
Sexual and Gender Minorities
/ statistics & numerical data
Young Adult
HIV
MSM
PrEP
PrEP-matching
serosorting
sexual mixing patterns
Journal
American journal of epidemiology
ISSN: 1476-6256
Titre abrégé: Am J Epidemiol
Pays: United States
ID NLM: 7910653
Informations de publication
Date de publication:
31 01 2020
31 01 2020
Historique:
received:
15
05
2019
revised:
27
09
2019
accepted:
27
09
2019
pubmed:
16
10
2019
medline:
1
5
2020
entrez:
16
10
2019
Statut:
ppublish
Résumé
Using cross-sectional survey data (Engage, 2017-2018) from 1,137 men who have sex with men, ≥16 years old, in Montreal, we compared observed human immunodeficiency virus (HIV) seroconcordance in previous-6-months' sexual partnerships with what would have been observed by chance if zero individuals serosorted. Of 5 recent partnerships where both individuals were HIV-negative, we compared observed concordance in preexposure prophylaxis (PrEP) use with the counterfactual if zero individuals selected partners based on PrEP use. We estimated the concordance by chance using a balancing-partnerships approach assuming proportionate mixing. HIV-positive respondents had a higher proportion of HIV-positive partners (66.4%, 95% confidence interval (CI): 64.0, 68.6) than by chance (23.9%, 95% CI: 23.1, 24.7). HIV-negative respondents (both on and not on PrEP) had higher proportions of HIV-negative partners (82.9% (95% CI: 81.1, 84.7) and 90.7% (95% CI: 89.6, 91.7), respectively) compared with by chance (76.1%, 95% CI: 75.3, 76.9); however, those on PrEP had a higher proportion of HIV-positive partners than those not on PrEP (17.1% (95% CI: 15.3, 18.9) vs. 9.3% (95% CI: 8.3, 10.4). Those on PrEP also had a higher proportion of partners on PrEP among their HIV-negative partners (50.6%, 95% CI: 42.5, 58.8) than by chance (28.5%, 95% CI: 27.5, 29.4). The relationship between PrEP and sexual-mixing patterns demonstrated by less population-level serosorting among those on PrEP and PrEP-matching warrants consideration during PrEP roll-out.
Identifiants
pubmed: 31612213
pii: 5587085
doi: 10.1093/aje/kwz231
pmc: PMC7119299
doi:
Substances chimiques
Anti-HIV Agents
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
44-54Subventions
Organisme : CIHR
ID : TE2-138299
Pays : Canada
Organisme : CIHR
ID : CTN 300
Pays : Canada
Organisme : CIHR
ID : FN-13455
Pays : Canada
Informations de copyright
© The Author(s) 2019. Published by Oxford University Press on behalf of the Johns Hopkins Bloomberg School of Public Health.
Références
AIDS Behav. 2016 Nov;20(11):2762-2771
pubmed: 26910338
PLoS One. 2017 May 30;12(5):e0178737
pubmed: 28558067
Int J Epidemiol. 2017 Oct 1;46(5):1582-1592
pubmed: 28605503
AIDS Behav. 2016 Jul;20(7):1408-22
pubmed: 26884310
AIDS Care. 2019 Mar;31(3):388-396
pubmed: 30301371
AIDS Patient Care STDS. 2015 Oct;29(10):559-68
pubmed: 26348322
AIDS Educ Prev. 2012 Dec;24(6):564-73
pubmed: 23206204
Lancet. 2012 Jul 28;380(9839):367-77
pubmed: 22819660
AIDS Behav. 2018 Aug;22(8):2743-2755
pubmed: 29550942
Sex Transm Infect. 2011 Mar;87(2):162-4
pubmed: 21076140
Proc Natl Acad Sci U S A. 2010 Apr 13;107(15):6743-7
pubmed: 20351258
J Acquir Immune Defic Syndr. 2008 Oct 1;49(2):212-8
pubmed: 18769346
Euro Surveill. 2009 Nov 26;14(47):
pubmed: 19941805
J Acquir Immune Defic Syndr. 2013 Nov 1;64(3):307-14
pubmed: 23846562
Sex Transm Dis. 2010 Jan;37(1):13-7
pubmed: 20118674
J Acquir Immune Defic Syndr. 2016 Feb 1;71(2):200-6
pubmed: 26761520
AIDS Patient Care STDS. 2018 Jan;32(1):24-30
pubmed: 29185801
Cult Health Sex. 2014 Feb 26;:
pubmed: 24571102
AIDS Behav. 2017 Oct;21(10):2935-2944
pubmed: 28097616
IMA J Math Appl Med Biol. 1994;11(3):161-92
pubmed: 7822888
Sex Transm Dis. 2018 Jun;45(6):368-373
pubmed: 29465690
AIDS. 2009 Aug 24;23(13):1617-29
pubmed: 19584704
AIDS Behav. 2012 Jan;16(1):121-31
pubmed: 21644001
J Urban Health. 2010 May;87(3):452-66
pubmed: 20217485
Curr HIV/AIDS Rep. 2013 Dec;10(4):305-13
pubmed: 24234489
AIDS Behav. 2017 Oct;21(10):2835-2843
pubmed: 28573378
J Int AIDS Soc. 2018 Jul;21 Suppl 5:e25130
pubmed: 30033536
Can J Infect Dis Med Microbiol. 2015 Jan-Feb;26(1):17-22
pubmed: 25798149
J Acquir Immune Defic Syndr. 2016 Jun 1;72(2):189-97
pubmed: 26885806
Sex Transm Infect. 2009 Oct;85(6):469-76
pubmed: 19505875
AIDS. 2009 Nov 27;23(18):2497-506
pubmed: 19834319
PLoS One. 2016 Sep 22;11(9):e0163159
pubmed: 27657492